Global Patent Index - EP 1453522 A1

EP 1453522 A1 20040908 - METHODS FOR TREATMENT OR PROPHYLAXIS OF ALDOSTERONE-MEDIATED PATHOGENIC EFFECTGS IN A SUBJECT USING AN EPOXY-STEROIDAL ALDOSTERONE ANTAGONIST

Title (en)

METHODS FOR TREATMENT OR PROPHYLAXIS OF ALDOSTERONE-MEDIATED PATHOGENIC EFFECTGS IN A SUBJECT USING AN EPOXY-STEROIDAL ALDOSTERONE ANTAGONIST

Title (de)

BEHANDLUNG- ODER VORBEUGUNGSMETHODEN VON ALDOSTERONBEDINGTEN PATHOGENEN WIRKUNGEN DURCH EPOXYSTEROIDALDOSTERONANTAGONISTEN

Title (fr)

METHODES DESTINEES A TRAITER OU PREVENIR DES EFFETS PATHOGENES INDUITS PAR L'ALDOSTERONE CHEZ UN SUJET AU MOYEN D'UN ANTAGONISTE D'ALDOSTERONE EPOXY-STEROIDIEN

Publication

EP 1453522 A1 20040908 (EN)

Application

EP 01998044 A 20011213

Priority

US 0148419 W 20011213

Abstract (en)

[origin: WO03051372A1] The present invention provides methods for the treatment or prophylaxis of one or more aldosterone-mediated pathogenic effects in a subject suffering from or susceptible to the pathogenic effect or effects wherein the subject has one or more conditions selected from the group consisting of a sub-normal endogenous aldosterone level, salt sensitivity and an elevated dietary sodium intake. The methods comprise administering to the subject a therapeutically-effective amount of one or more epoxy-steroidal compounds that are aldosterone antagonists.

IPC 1-7

A61K 31/585; A61P 5/42

IPC 8 full level

A61K 31/585 (2006.01); A61P 1/16 (2006.01); A61P 3/10 (2006.01); A61P 5/28 (2006.01); A61P 5/42 (2006.01); A61P 7/10 (2006.01); A61P 9/04 (2006.01); A61P 9/10 (2006.01); A61P 9/12 (2006.01); A61P 11/00 (2006.01); A61P 13/12 (2006.01); A61P 15/00 (2006.01); A61P 25/00 (2006.01); A61P 25/06 (2006.01); C07J 71/00 (2006.01)

CPC (source: EP KR)

A61K 31/569 (2013.01 - KR); A61K 31/58 (2013.01 - KR); A61K 31/585 (2013.01 - EP KR); A61P 1/16 (2017.12 - EP); A61P 3/10 (2017.12 - EP); A61P 5/28 (2017.12 - EP); A61P 5/42 (2017.12 - EP); A61P 7/10 (2017.12 - EP); A61P 9/04 (2017.12 - EP); A61P 9/10 (2017.12 - EP); A61P 9/12 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 13/12 (2017.12 - EP); A61P 15/00 (2017.12 - EP); A61P 25/00 (2017.12 - EP); A61P 25/06 (2017.12 - EP)

Citation (search report)

See references of WO 03051372A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

DOCDB simple family (publication)

WO 03051372 A1 20030626; AU 2002249804 A1 20030630; BR 0117195 A 20050209; CA 2469950 A1 20030626; EP 1453522 A1 20040908; IL 162393 A0 20051120; JP 2005516015 A 20050602; KR 20040071723 A 20040812; MX PA04005803 A 20041101

DOCDB simple family (application)

US 0148419 W 20011213; AU 2002249804 A 20011213; BR 0117195 A 20011213; CA 2469950 A 20011213; EP 01998044 A 20011213; IL 16239301 A 20011213; JP 2003552305 A 20011213; KR 20047009192 A 20011213; MX PA04005803 A 20011213